1. Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany;
2. Department of Pathology, University of Barcelona, Hospital Clinic, Barcelona, Spain;
3. Biometric Research Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD;
4. Department of Hematology, Oncology and Tumor Immunology, Charite Universitätsmedizin Berlin, Berlin, Germany;
5. Institute of Human Genetics, Christian-Albrechts University, Kiel, Germany;
6. Bioinformatics and Molecular Analysis Section, Division of Computational Bioscience, Center for Information Technology, NIH, Bethesda, MD;
7. Southwest Oncology Group, Oregon Health & Science University, Portland;
8. Department of Pathology, University of Arizona, Tucson;
9. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha;
10. Norwegian Radium Hospital, Oslo, Norway;
11. Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD;
12. British Columbia Cancer Agency, Vancouver, BC;
13. Department of Medicine, Duke University Medical Center, Durham, NC;
14. Metabolism Branch, National Cancer Institute, NIH, Bethesda, MD; and
15. Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany